Last Updated: Aug 30, 2016
- High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
Rashid Muhammad Usman, et al. BMC cancer 2016 0 (1) 673 - Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
Pinto Pedro, et al. Breast cancer research and treatment 2016 8 - All women with ovarian cancer should be offered genetic testing – so why aren’t they?
E Smith, Science Blogs, August 17, 2016 - BRCA 1/2-negative patients who receive counseling after genetic testing have lower anxiety.
Printz Carrie et al. Cancer 2016 Apr 122(8) 1149 - Changing patterns of referrals and outcomes of genetic participation in gynaecological-oncology multidisciplinary care.
Pokharel Hanoon P et al. The Australian & New Zealand journal of obstetrics & gynaecology 2016 Aug - Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial.
Pasick Rena J et al. American journal of public health 2016 Aug e1-e7 - All women with ovarian cancer should be offered genetic testing – so why aren’t they?
E Smith, Science Blogs, August 17, 2016 - Hereditary breast and ovarian cancer: new genes in confined pathways.
Nielsen Finn Cilius, et al. Nature reviews. Cancer 2016 8 - Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial.
Kiechle Marion et al. Trials 2016 17368 - Evolution of Hereditary Breast Cancer Genetic Services: Are Changes Reflected in the Knowledge and Clinical Practices of Florida Providers?
Cragun Deborah et al. Genetic testing and molecular biomarkers 2016 Aug - Finding all BRCA pathogenic mutation carriers: best practice models.
Hoogerbrugge Nicoline et al. European journal of human genetics : EJHG 2016 Sep 24 Suppl 1S19-26 - How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
Watts Kaaren J et al. BMC cancer 2012 12320 - Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Wright Alexi A et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Aug - Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT).
Joseph Galen et al. Journal of genetic counseling 2010 Oct 19(5) 447-62 - Stakeholder consultation insights on the future of genomics at the clinical-public health interface.
Modell Stephen M et al. Translational research : the journal of laboratory and clinical medicine 2014 May 163(5) 466-77
- Human (51)
- Pathogen (0)
- Human (1486)
- Pathogen (0)
- Human (223)
- Pathogen (0)
- Huamn (112)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario